C1-Esterase Inhibitor (Recombinant) Injection

hereditary angioedema (HAE): A rare inherited condition where the body lacks enough functional C1-esterase inhibitor, causing sudden episodes of swelling under the skin or in the gut and throat.

C1-esterase inhibitor (C1INH): A protein normally found in the blood that regulates the complement and contact systems to prevent unwanted swelling and inflammation.

recombinant: Made in a laboratory using genetic technology rather than derived from human blood or tissue.

intravenous (IV): Given directly into a vein, allowing the medication to enter the bloodstream immediately.

anaphylaxis: A severe, potentially life-threatening allergic reaction that can cause throat swelling, breathing difficulty, a dangerous drop in blood pressure, and shock.

thromboembolic event: A blood clot that forms in a blood vessel (thrombosis) and may break off and travel to another part of the body (embolism), potentially causing serious harm.

laryngeal attack: An HAE attack that causes swelling in the larynx (voice box/throat), which can block the airway and become life-threatening.

bradykinin: A chemical the body produces that causes blood vessel walls to become leaky, leading to swelling — overproduced during an HAE attack.

plasma kallikrein: An enzyme in the blood that helps generate bradykinin; one of the key targets that C1-esterase inhibitor blocks to stop HAE attacks.

factor XIIa: An enzyme in the blood's contact system that triggers a chain reaction leading to bradykinin production; blocked by C1-esterase inhibitor.

complement system: A part of the immune system made up of proteins that work together to fight infection and regulate inflammation.

contact system: A group of blood proteins that, when activated, trigger inflammation and blood-vessel leakage — overactivated in HAE attacks.

vascular permeability: How easily fluid can pass through blood vessel walls; when too high, fluid leaks into surrounding tissue and causes swelling.

reconstitution: The process of dissolving a powdered medication in a liquid (such as sterile water) to prepare it for injection.

half-life: The time it takes for the body to reduce the concentration of a drug in the blood by half; a short half-life means the drug clears quickly.

immunogenicity: The tendency of a medication (especially a protein-based one) to trigger the immune system to produce antibodies against it.

aseptic technique: A careful method of handling medical products and equipment to prevent contamination with bacteria or other germs.

serine protease inhibitor (serpin): A type of protein that controls enzyme activity by binding to and inactivating specific enzymes (proteases) in the body.

on-demand treatment: A medication taken only when symptoms occur, not on a regular daily schedule.

indwelling venous catheter: A small tube placed and left inside a vein to allow repeated access to the bloodstream, sometimes used for ongoing medical treatment.

atherosclerosis: A condition where fatty deposits build up inside artery walls, narrowing them and increasing the risk of blood clots and heart events.

pharmacokinetics: The study of how the body absorbs, distributes, processes, and eliminates a drug over time.

pharmacodynamics: The study of what a drug does to the body — its measurable effects and how it produces them.

complement component C4: A blood protein that acts as a marker for complement system activity; levels are typically low in HAE patients and rise toward normal after Ruconest treatment.

neutralizing antibody: An antibody produced by the immune system that blocks a drug from working; none were detected against Ruconest's active ingredient in clinical trials.

thrombosis: The formation of a blood clot inside a blood vessel, which can partially or completely block blood flow.

contraindication: A specific condition or factor that makes using a particular medication dangerous or inadvisable.

organogenesis: The period during pregnancy when a fetus's organs are forming — a critical window for assessing drug safety during development.

nonlinear clearance: A pattern where the body clears a drug more slowly at higher doses, rather than at a consistent rate — meaning higher doses stay active longer.

adolescent: In this context, a person between 13 and 17 years of age, as defined in the Ruconest clinical studies.

abdominal pain: Pain, cramping, or discomfort felt anywhere in the belly area.

adverse reaction: An unwanted or harmful effect that a medicine causes in the body.

Adverse Reactions: Unwanted or harmful effects that people experienced while taking a medicine, listed on its official label.

angioedema: Rapid swelling deep under the skin, often around the eyes, lips, tongue, or throat.

clearance: How quickly the body removes a medicine from the blood, usually through the liver and kidneys.

Clinical Studies: The label section summarizing the research trials used to show that a medicine works and is acceptably safe.

diarrhea: Loose, watery bowel movements that happen more often than normal.

Dosage and Administration: The label section explaining how much of a medicine to use and how to take or give it.

Drug Interactions: The label section listing other medicines, foods, or substances that can change how a medicine works or raise the chance of side effects.

efficacy: How well a treatment works under the controlled conditions of a clinical study.

Elimination: The overall removal of a medicine from the body by breaking it down and passing it out.

hypersensitivity: An overreaction of the body's defense system to a substance, causing symptoms such as rash, swelling, or trouble breathing.

Indications and Usage: The label section stating which medical conditions the FDA has officially approved the medicine to treat, prevent, or manage.

infusion: Slowly delivering fluid or medicine into a vein over a period of time, usually through a drip.

inhibitor: A substance that blocks an enzyme or transporter, which can raise the levels of drugs it normally handles.

intravenous: Given directly into a vein through a needle or thin tube; often written as IV.

Warnings and Precautions: The label section describing serious risks to know about and safety steps to follow while using a medicine.

wheezing: A high-pitched whistling sound made while breathing, usually when the airways are narrowed.